Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Compulsory licensing
New Database Documents the Power of TRIPS Flexibilities
Ellen 't Hoen
-
November 27, 2018
Opmerkingen bij de notitie Dwanglicenties van B.J. Bruins, Minister voor Medische...
Ellen 't Hoen
-
July 10, 2018
European Pharmaceutical Legislation Needs Exceptions to Data and Market Exclusivity to...
Ellen 't Hoen
-
May 21, 2018
Brazil’s Federal Court Reviews Medicines Mailbox Patents
Ellen 't Hoen
-
April 29, 2018
The Power of TRIPS Flexibilities in Medicines Procurement
Ellen 't Hoen
-
April 9, 2018
Wrapping Up 2017 – some noteworthy medicines law and policy events.
Ellen 't Hoen
-
December 31, 2017
Medicines Excitement in the Netherlands – New Health Minister announces...
Ellen 't Hoen
-
November 24, 2017
Modifier la législation européenne pour mettre en œuvre la licence d’office...
Pascale Boulet
-
November 14, 2017
The Most Common Misunderstanding about Compulsory Licensing
Ellen 't Hoen
-
May 25, 2017
The Italian Exception – A personalised approach to accessing high-priced patented...
Ellen 't Hoen
-
May 5, 2017
1
2
3
Page 2 of 3
This work is licensed under Creative Commons.